Compare LC & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LC | PAHC |
|---|---|---|
| Founded | 2006 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.6B |
| IPO Year | 2014 | 2014 |
| Metric | LC | PAHC |
|---|---|---|
| Price | $19.92 | $39.42 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 4 |
| Target Price | $22.67 | ★ $31.25 |
| AVG Volume (30 Days) | ★ 1.6M | 261.7K |
| Earning Date | 01-27-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 1.21% |
| EPS Growth | 93.62 | ★ 288.74 |
| EPS | 0.89 | ★ 1.67 |
| Revenue | $1,296,102,000.00 | ★ $1,399,676,000.00 |
| Revenue This Year | N/A | $15.34 |
| Revenue Next Year | $16.49 | $3.28 |
| P/E Ratio | ★ $22.41 | $23.67 |
| Revenue Growth | 16.98 | ★ 33.72 |
| 52 Week Low | $7.90 | $16.16 |
| 52 Week High | $20.94 | $46.42 |
| Indicator | LC | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 57.78 | 49.57 |
| Support Level | $18.74 | $36.47 |
| Resistance Level | $20.30 | $38.49 |
| Average True Range (ATR) | 0.63 | 1.46 |
| MACD | -0.03 | 0.18 |
| Stochastic Oscillator | 80.71 | 56.42 |
LendingClub Corp is a company engaged in operating an online lending marketplace platform that connects borrowers and investors for the provision of the loan facility. It offers investors access to an asset class that has generally been closed to many investors and only available on a limited basis to institutional investors. The company through the platform offers loan products such as personal, education and patient finance, small business, and auto to interested investors. It generates a majority of the revenue from the transaction fees received from the platform's role in accepting and decisioning applications on behalf of the bank partners to enable loan originations.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.